These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 30244162)
1. Reduced phenotypic expression in genetic hemochromatosis with time: Role of exposure to non-genetic modifiers. Deugnier Y; Morcet J; Lainé F; Hamdi-Roze H; Bollard AS; Guyader D; Moirand R; Bardou-Jacquet E J Hepatol; 2019 Jan; 70(1):118-125. PubMed ID: 30244162 [TBL] [Abstract][Full Text] [Related]
2. Correlation between iron status and genetic hemochromatosis (codon C282Y) in a large German population. Wrede CE; Hutzler S; Bollheimer LC; Buettner R; Hellerbrand C; Schöelmerich J; Palitzsch KD Isr Med Assoc J; 2004 Jan; 6(1):30-3. PubMed ID: 14740507 [TBL] [Abstract][Full Text] [Related]
3. [Molecular genetic diagnostics and screening of hereditary hemochromatosis]. Zlocha J; Kovács L; Pozgayová S; Kupcová V; Durínová S Vnitr Lek; 2006 Jun; 52(6):602-8. PubMed ID: 16871764 [TBL] [Abstract][Full Text] [Related]
4. MRI-Based Iron Phenotyping and Patient Selection for Next-Generation Sequencing of Non-Homeostatic Iron Regulator Hemochromatosis Genes. Viveiros A; Schaefer B; Panzer M; Henninger B; Plaikner M; Kremser C; Franke A; Franzenburg S; Hoeppner MP; Stauder R; Janecke A; Tilg H; Zoller H Hepatology; 2021 Nov; 74(5):2424-2435. PubMed ID: 34048062 [TBL] [Abstract][Full Text] [Related]
5. Iron loading and morbidity among relatives of HFE C282Y homozygotes identified either by population genetic testing or presenting as patients. McCune CA; Ravine D; Carter K; Jackson HA; Hutton D; Hedderich J; Krawczak M; Worwood M Gut; 2006 Apr; 55(4):554-62. PubMed ID: 16174659 [TBL] [Abstract][Full Text] [Related]
6. Hemochromatosis and iron-overload screening in a racially diverse population. Adams PC; Reboussin DM; Barton JC; McLaren CE; Eckfeldt JH; McLaren GD; Dawkins FW; Acton RT; Harris EL; Gordeuk VR; Leiendecker-Foster C; Speechley M; Snively BM; Holup JL; Thomson E; Sholinsky P; N Engl J Med; 2005 Apr; 352(17):1769-78. PubMed ID: 15858186 [TBL] [Abstract][Full Text] [Related]
7. HFE genotype in patients with hemochromatosis and other liver diseases. Bacon BR; Olynyk JK; Brunt EM; Britton RS; Wolff RK Ann Intern Med; 1999 Jun; 130(12):953-62. PubMed ID: 10383365 [TBL] [Abstract][Full Text] [Related]
8. Clinical expression of haemochromatosis in Irish C282Y homozygotes identified through family screening. Gleeson F; Ryan E; Barrett S; Crowe J Eur J Gastroenterol Hepatol; 2004 Sep; 16(9):859-63. PubMed ID: 15316409 [TBL] [Abstract][Full Text] [Related]
9. Hepatic iron overload: direct HFE (HLA-H) mutation analysis vs quantitative iron assays for the diagnosis of hereditary hemochromatosis. Press RD; Flora K; Gross C; Rabkin JM; Corless CL Am J Clin Pathol; 1998 May; 109(5):577-84. PubMed ID: 9576576 [TBL] [Abstract][Full Text] [Related]
10. A genotypic study of 217 unrelated probands diagnosed as "genetic hemochromatosis" on "classical" phenotypic criteria. Brissot P; Moirand R; Jouanolle AM; Guyader D; Le Gall JY; Deugnier Y; David V J Hepatol; 1999 Apr; 30(4):588-93. PubMed ID: 10207799 [TBL] [Abstract][Full Text] [Related]
11. A population-based study of the clinical expression of the hemochromatosis gene. Olynyk JK; Cullen DJ; Aquilia S; Rossi E; Summerville L; Powell LW N Engl J Med; 1999 Sep; 341(10):718-24. PubMed ID: 10471457 [TBL] [Abstract][Full Text] [Related]
12. GNPAT variant (D519G) is not associated with an elevated serum ferritin or iron removed by phlebotomy in patients referred for C282Y-linked hemochromatosis. Levstik A; Stuart A; Adams PC Ann Hepatol; 2016 Nov-Dec 2016; 15(6):907-910. PubMed ID: 27740525 [TBL] [Abstract][Full Text] [Related]
13. Decreased iron burden in overweight C282Y homozygous women: Putative role of increased hepcidin production. Desgrippes R; Lainé F; Morcet J; Perrin M; Manet G; Jezequel C; Bardou-Jacquet E; Ropert M; Deugnier Y Hepatology; 2013 May; 57(5):1784-92. PubMed ID: 23322654 [TBL] [Abstract][Full Text] [Related]
14. Penetrance of Hemochromatosis in HFE Genotypes Resulting in p.Cys282Tyr and p.[Cys282Tyr];[His63Asp] in the eMERGE Network. Gallego CJ; Burt A; Sundaresan AS; Ye Z; Shaw C; Crosslin DR; Crane PK; Fullerton SM; Hansen K; Carrell D; Kuivaniemi H; Derr K; de Andrade M; McCarty CA; Kitchner TE; Ragon BK; Stallings SC; Papa G; Bochenek J; Smith ME; Aufox SA; Pacheco JA; Patel V; Friesema EM; Erwin AL; Gottesman O; Gerhard GS; Ritchie M; Motulsky AG; Kullo IJ; Larson EB; Tromp G; Brilliant MH; Bottinger E; Denny JC; Roden DM; Williams MS; Jarvik GP Am J Hum Genet; 2015 Oct; 97(4):512-20. PubMed ID: 26365338 [TBL] [Abstract][Full Text] [Related]
15. HLA haplotype A*03-B*07 in hemochromatosis probands with HFE C282Y homozygosity: frequency disparity in men and women and lack of association with severity of iron overload. Barton JC; Wiener HW; Acton RT; Go RC Blood Cells Mol Dis; 2005; 34(1):38-47. PubMed ID: 15607698 [TBL] [Abstract][Full Text] [Related]
16. Genotypic/phenotypic correlations in genetic hemochromatosis: evolution of diagnostic criteria. Adams PC; Chakrabarti S Gastroenterology; 1998 Feb; 114(2):319-23. PubMed ID: 9453492 [TBL] [Abstract][Full Text] [Related]
17. Iron-overload-related disease in HFE hereditary hemochromatosis. Allen KJ; Gurrin LC; Constantine CC; Osborne NJ; Delatycki MB; Nicoll AJ; McLaren CE; Bahlo M; Nisselle AE; Vulpe CD; Anderson GJ; Southey MC; Giles GG; English DR; Hopper JL; Olynyk JK; Powell LW; Gertig DM N Engl J Med; 2008 Jan; 358(3):221-30. PubMed ID: 18199861 [TBL] [Abstract][Full Text] [Related]
18. Worse Outcomes of Patients With HFE Hemochromatosis With Persistent Increases in Transferrin Saturation During Maintenance Therapy. Bardou-Jacquet E; Lainé F; Guggenbuhl P; Morcet J; Jézéquel C; Guyader D; Moirand R; Deugnier Y Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1620-1627. PubMed ID: 28111337 [TBL] [Abstract][Full Text] [Related]